By Dave Andrusko
Pro-abortionists insist chemical abortions are “safer than Tylenol,” according to Bloomberg News. Pro-lifers point to the thousands of “adverse events” and the more than two dozen dead women whose death are associated with the two-drug abortion technique.
Alas, another woman was added to the toll of victims this week.
News 9 of India reports that “a 33-year-old woman in Bengaluru died on Tuesday after consuming an over-the-counter abortion pill, police said. The police identified the deceased as Priti Kushwaha, an employee of an e-commerce company in the city.”
The story does not identify the drug or drugs that she took, but many Indian pharmaceutical manufacturers make packets of mifepristone (RU-486) and misoprostol which are sold in India and sometimes shipped to the U.S. The purity, safety, and effectiveness of these pills have generally not been tested by the U.S. Food and Drug Administration (FDA).
According to news accounts, on Saturday, Kushwaha, the mother of an 11-month-old son, found out she was pregnant after taking a home pregnancy test. She did not want the baby and “when she told her husband Devbrath, who works as a software engineer in Bengaluru, he said that they visited a hospital to get the procedure done.”
Her husband reportedly insisted they get the abortion pills from a hospital which upset Kushwaha, who wanted her husband to get them for her. She took the abortion pills and “On Monday, around 9 pm, Kushwaha called Devbrath, who was out on his evening walk, and told him that she was bleeding” and was suffering severe pain.
Unfortunately, Kushwaha rejected her husband’s suggestion to go to the hospital. Her motive in insisting on staying at home is unknown.
Early on Tuesday morning, Kushwaha lost consciousness. “Immediately, Devbrath and the woman’s brother Navneet took her to the hospital. However, she was declared dead on arrival by the hospital.”
Last December, the Biden administration’s FDA began allowing U.S. abortionists to sell abortion drugs through the mail without an in-person visit by the woman with a healthcare provider. “Although a licensed medical professional is still supposed to be involved, often the only interaction is chatting with a woman briefly over the phone from hundreds of miles away before mailing the drugs to her,” according to Micaiah Bilger.
It is unclear whether some women even get this direct phone contact, and the abortion industry has tried to argue that these sort of pills can be mailed without the woman undergoing any testing or screening at all.
If this model prevails in the U.S., there will certainly be more women perishing like Kushwaha, receiving pills of dubious composition and quality, never being checked or monitored for deadly conditions like ectopic pregnancy (which the pills do not treat) or hemorrhage from a failed abortion (which may be a consequence of the pills being used too late in the gestation).
Already, Bilger says “some abortion activists in the U.S. recently admitted to smuggling abortion drugs across the Mexico border and sending broken and mislabeled pills to women or, possibly, their abusers – without the involvement of any licensed medical provider at all.”